Bioaccumulation and analytics of pharmaceutical residues in the environment: A review

A Puckowski, K Mioduszewska, P Łukaszewicz… - … of pharmaceutical and …, 2016 - Elsevier
The presence of pharmaceutical residues in various environmental compartments is an
issue of increasing concern. The widespread occurrence of these compounds in water and …

Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations

D Achelrod, U Wenzel, S Frey - American journal of hypertension, 2015 - academic.oup.com
BACKGROUND Although treatment-resistant hypertension (RH) is a serious burden on
population health, there exists uncertainty about its prevalence. Hence, the objectives of this …

Incidence and prognosis of resistant hypertension in hypertensive patients

SL Daugherty, JD Powers, DJ Magid, HM Tavel… - Circulation, 2012 - Am Heart Assoc
Background—Despite a recent American Heart Association (AHA) consensus statement
emphasizing the importance of resistant hypertension, the incidence and prognosis of this …

[HTML][HTML] Renal nerve ablation for resistant hypertension: the dust has not yet settled

M Doumas, A Lazaridis… - The Journal of Clinical …, 2014 - ncbi.nlm.nih.gov
Resistant hypertension represents a major clinical problem in everyday clinical practice, not
only for hypertension experts but for nephrologists, cardiologists, internists, and primary care …

Effects of antihypertensive drugs on arterial stiffness

T Dudenbostel, SP Glasser - Cardiology in review, 2012 - journals.lww.com
In this review, we discuss the possible pathophysiological mechanisms and the role of
arterial stiffness as a biomarker, a blood pressure–independent predictor of cardiovascular …

Renal denervation: ultima ratio or standard in treatment-resistant hypertension

A Persu, J Renkin, L Thijs, JA Staessen - Hypertension, 2012 - Am Heart Assoc
The term “ultima ratio” has multiple, though related, meanings. The motto “ultima ratio
regum,” cast on the cannons of the French army of King Louis XIV, meant that war is the last …

Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel

D Weitzman, G Chodick, V Shalev, C Grossman… - …, 2014 - Am Heart Assoc
Previous assessments of the prevalence of resistant hypertension (RH) in uncontrolled
blood pressure (BP) have ranged from 3% to 30%. Using real-world data, our aim was to …

The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension

SL Daugherty, JD Powers, DJ Magid, FA Masoudi… - …, 2012 - Am Heart Assoc
Patients with resistant hypertension are at risk for poor outcomes. Medication adherence
and intensification improve blood pressure (BP) control; however, little is known about these …

[HTML][HTML] Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation

JR Gomolak, SP Didion - Frontiers in physiology, 2014 - frontiersin.org
Angiotensin II (Ang II) is associated with vascular hypertrophy, endothelial dysfunction and
activation of a number of inflammatory molecules, however the linear events involved in the …

[HTML][HTML] Medication adherence and treatment-resistant hypertension: a review

MA Hameed, I Dasgupta - Drugs in context, 2019 - ncbi.nlm.nih.gov
Nonadherence is a common reason for treatment failure and treatment resistance. No matter
how it is defined, it is a major issue in the management of chronic illnesses. There are …